Many inflammatory diseases, including rheumatoid arthritis, asthma, and psoriasis, show upregulated levels of TIMP-1, suggesting that this protein could be a promising therapeutic target for the development of new anti-inflammatory treatments [9]. Here, TIMP1 is linked to rheumatoid arthritis.